SLC5A2 and bullous pemphigoid: Inhibition of dipeptidylpeptidase-4 activity may lead to the onset of bullous pemphigoid, and induction of glucosuria by sodium-glucose cotransporter 2 inhibitors may promote the development of Fournier’s gangrene.